151 related articles for article (PubMed ID: 28463515)
1. Rational Design of Bisubstrate-Type Analogues as Inhibitors of DNA Methyltransferases in Cancer Cells.
Halby L; Menon Y; Rilova E; Pechalrieu D; Masson V; Faux C; Bouhlel MA; David-Cordonnier MH; Novosad N; Aussagues Y; Samson A; Lacroix L; Ausseil F; Fleury L; Guianvarc'h D; Ferroud C; Arimondo PB
J Med Chem; 2017 Jun; 60(11):4665-4679. PubMed ID: 28463515
[TBL] [Abstract][Full Text] [Related]
2. Procainamide is a specific inhibitor of DNA methyltransferase 1.
Lee BH; Yegnasubramanian S; Lin X; Nelson WG
J Biol Chem; 2005 Dec; 280(49):40749-56. PubMed ID: 16230360
[TBL] [Abstract][Full Text] [Related]
3. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer.
Singh V; Sharma P; Capalash N
Curr Cancer Drug Targets; 2013 May; 13(4):379-99. PubMed ID: 23517596
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer.
Liu B; Song J; Luan J; Sun X; Bai J; Wang H; Li A; Zhang L; Feng X; Du Z
Exp Biol Med (Maywood); 2016 Aug; 241(14):1531-9. PubMed ID: 27190263
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
6. Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer.
Li YC; Wang Y; Li DD; Zhang Y; Zhao TC; Li CF
J Cell Biochem; 2018 Feb; 119(2):2440-2449. PubMed ID: 28926119
[TBL] [Abstract][Full Text] [Related]
7. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.
Schneider-Stock R; Diab-Assef M; Rohrbeck A; Foltzer-Jourdainne C; Boltze C; Hartig R; Schönfeld P; Roessner A; Gali-Muhtasib H
J Pharmacol Exp Ther; 2005 Feb; 312(2):525-36. PubMed ID: 15547111
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of 4-amino-N- (4-aminophenyl)benzamide analogues of quinoline-based SGI-1027 as inhibitors of DNA methylation.
Rilova E; Erdmann A; Gros C; Masson V; Aussagues Y; Poughon-Cassabois V; Rajavelu A; Jeltsch A; Menon Y; Novosad N; Gregoire JM; Vispé S; Schambel P; Ausseil F; Sautel F; Arimondo PB; Cantagrel F
ChemMedChem; 2014 Mar; 9(3):590-601. PubMed ID: 24678024
[TBL] [Abstract][Full Text] [Related]
9. Mammalian cytosine DNA methyltransferase Dnmt1: enzymatic mechanism, novel mechanism-based inhibitors, and RNA-directed DNA methylation.
Svedruzić ZM
Curr Med Chem; 2008; 15(1):92-106. PubMed ID: 18220765
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation.
Kudo G; Hirao T; Harada R; Hirokawa T; Shigeta Y; Yoshino R
Sci Rep; 2024 Jun; 14(1):13508. PubMed ID: 38866895
[TBL] [Abstract][Full Text] [Related]
11. Insight into the selective binding mechanism of DNMT1 and DNMT3A inhibitors: a molecular simulation study.
Xie T; Yu J; Fu W; Wang Z; Xu L; Chang S; Wang E; Zhu F; Zeng S; Kang Y; Hou T
Phys Chem Chem Phys; 2019 Jun; 21(24):12931-12947. PubMed ID: 31165133
[TBL] [Abstract][Full Text] [Related]
12. Black raspberry-derived anthocyanins demethylate tumor suppressor genes through the inhibition of DNMT1 and DNMT3B in colon cancer cells.
Wang LS; Kuo CT; Cho SJ; Seguin C; Siddiqui J; Stoner K; Weng YI; Huang TH; Tichelaar J; Yearsley M; Stoner GD; Huang YW
Nutr Cancer; 2013; 65(1):118-25. PubMed ID: 23368921
[TBL] [Abstract][Full Text] [Related]
13. In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1.
Miletić V; Odorčić I; Nikolić P; Svedružić ŽM
PLoS One; 2017; 12(4):e0174410. PubMed ID: 28399172
[TBL] [Abstract][Full Text] [Related]
14. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
Fandy TE
Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
[TBL] [Abstract][Full Text] [Related]
15. New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.
Gros C; Fleury L; Nahoum V; Faux C; Valente S; Labella D; Cantagrel F; Rilova E; Bouhlel MA; David-Cordonnier MH; Dufau I; Ausseil F; Mai A; Mourey L; Lacroix L; Arimondo PB
J Biol Chem; 2015 Mar; 290(10):6293-302. PubMed ID: 25525263
[TBL] [Abstract][Full Text] [Related]
16. Methods for the design and analysis of oligodeoxynucleotide-based DNA (cytosine-5) methyltransferase inhibitors.
Clark J; Shevchuk T; Kho MR; Smith SS
Anal Biochem; 2003 Oct; 321(1):50-64. PubMed ID: 12963055
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth.
Lin J; Haffner MC; Zhang Y; Lee BH; Brennen WN; Britton J; Kachhap SK; Shim JS; Liu JO; Nelson WG; Yegnasubramanian S; Carducci MA
Prostate; 2011 Mar; 71(4):333-43. PubMed ID: 20809552
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel DNA methyltransferase 3A inhibitors via structure-based virtual screening and biological assays.
Shao Z; Xu P; Xu W; Li L; Liu S; Zhang R; Liu YC; Zhang C; Chen S; Luo C
Bioorg Med Chem Lett; 2017 Jan; 27(2):342-346. PubMed ID: 27899265
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of NSC 106084 and NSC 14778 and evaluation of their DNMT inhibitory activity.
Leroy M; Mélin L; LaPlante SR; Medina-Franco JL; Gagnon A
Bioorg Med Chem Lett; 2019 Mar; 29(6):826-831. PubMed ID: 30704813
[TBL] [Abstract][Full Text] [Related]
20. Development of a universal radioactive DNA methyltransferase inhibition test for high-throughput screening and mechanistic studies.
Gros C; Chauvigné L; Poulet A; Menon Y; Ausseil F; Dufau I; Arimondo PB
Nucleic Acids Res; 2013 Oct; 41(19):e185. PubMed ID: 23980028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
